Airfinity launches free obesity market newsletter to provide critical updates to senior leaders

Posted on Oct 26, 2023

Current estimates indicate 650 million people are obese globally, and the US alone spends $173 Bn/year in obesity-related healthcare costs. This demonstrates the size of the anti-obesity market and impact new treatments could have on the global landscape.

Airfinity's new obesity market intelligence newsletter provides a free, curated summary of the latest news, commentary, and scientific results delivered to your inbox every week. Our team monitors and assesses the entire anti-obesity landscape, spanning hundreds of data sources and channels, in order to get you the most important information and give answers to the critical questions:

Clinical Developments

What does the current pipeline look like, from pre-clinical through to post-approval? What are the latest partnerships to be announced?

Commercial Developments

What does current manufacturing capacity look like and how might anticipated demand impact future production efforts?

Regulatory Developments

What are the new submissions and approvals in the space? Are we seeing any shifts in drug pricing regulations, reimbursement policies, or negotiations between pharmaceutical companies and payers? What is being done to control and prevent counterfeit or substandard medications from entering the market?

Disease Outcomes

What is the latest analysis and understanding around the wider economic impact of current anti-obesity drugs, and their role in reducing disease burden across other CVRM diseases?

Register for the free newsletter here.

Sign up to our Newsletter!

More Insights From Airfinity

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases

Oct 10, 2022

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers

Aug 25, 2022

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir

Jul 25, 2022

COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market

Jul 15, 2022

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination

Jul 13, 2022

Global wastage of COVID-19 vaccines could be 1.1 billion doses

Jul 11, 2022